Bank Of America Corp Syros Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.69 - $1.21 $2,447 - $4,291	-3,547 Reduced 12.64%	24,510 $23,000
Q1 2022 May 16, 2022	SELL	$1.02 - $3.8 $14,728 - $54,872	-14,440 Reduced 33.98%	28,057 $34,000
Q4 2021 Feb 08, 2022	BUY	$3.26 - $4.66 $37,010 - $52,904	11,353 Added 36.45%	42,497 $139,000
Q3 2021 Nov 15, 2021	SELL	$4.08 - $5.66 $7,629 - $10,584	-1,870 Reduced 5.66%	31,144 $139,000
Q2 2021 Sep 13, 2021	BUY	$5.01 - $7.48 $165,400 - $246,944	33,014 New	33,014 $180,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.